Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 42043180.
- Also identified by DOI 10.14309/ajg.0000000000004031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nosocomial infections (NI) in cirrhosis are associated with high mortality but could be preventable. Logistic regression (LR) models have failed to identify high-risk patients. We aimed to develop machine learning (ML) models to predict NI. The CLEARED consortium consists of prospectively enrolled cirrhosis inpatients from >120 centers. Using day-of-admission clinical data, three ML approaches[Random Forest (RF), Extreme Gradient Boosting (XGBoost), and Neural Networks (NN)] were used to predict NI. Data were split 80:20 for training and testing stratified by the outcome. Models were compared using Area-under-Receiver-operating-characteristic curve (AUC). 8,263 patients (55.90±13.34 years; 64.1% men) from 127 centers in 37 countries were included. NI developed in 869 (10.5%) a median of 6 (4-11) days post-admission. Major NIs were respiratory (29.6%) and urinary tract infection (15.7%), and spontaneous bacterial peritonitis (13.5%). NIs occurred more frequently in patients from low/low-middle income countries and those with severe liver disease, alcohol etiology, and admission infections. NIs were associated with inpatient mortality (31.9% vs. 8.1%, p<0.001) and liver transplantation (4.8% vs. 1.9%, p<0.001). While the RF model (AUC 0.69) showed good calibration (Brier score 0.09), outperforming XGBoost, NN, and LR models (AUC 0.66 for all; LR comparison p = 0.043), no model achieved AUC ≥0.80 for clinical utility. At 10% predicted probability threshold, RF model demonstrated only 75.4% sensitivity, 52.9% specificity, and 15.9% PPV. NIs cannot be accurately predicted from day-of-admission data using ML models, even in a large, prospective, global cirrhosis cohort. Every hospitalized patient with cirrhosis should receive protocolized infection-control measures.